DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Ausgabe 01 · Volume 49 · Februar 2023 DOI: 10.1055/s-013-56281 Maintaining Hemostasis and Preventing Thrombosis in COVID-19—Part IV Guest Editors: Emmanuel J. Favaloro, PhD, FFSc (RCPA), Leonardo Pasalic, FRCPA, FRACP, PhD, and Giuseppe Lippi, MD

Editorial

  • 001
    Favaloro, Emmanuel J.:

    Welcome to Seminars in Thrombosis & Hemostasis 2023

    • Preface

  • 003
    Favaloro, Emmanuel J.; Pasalic, Leonardo; Lippi, Giuseppe:

    Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV

    • Review Article

  • 009
    Zidan, Ali; Noureldin, Abdelrahman; Kumar, Shreya Anil; Elsebaie, Abdelrahman; Othman, Maha:

    COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications

  • 015
    Franchini, Massimo; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Moretti, Ugo; Focosi, Daniele; Tuccori, Marco:

    Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review

    Supplementary Material (PDF)
  • 027
    Lippi, Giuseppe; Favaloro, Emmanuel J.:

    What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19

  • 034
    Buso, Giacomo; Mazzolai, Lucia; Rueda-Camino, José Antonio; Fernández-Capitán, Carmen; Jiménez, David; Bikdeli, Behnood; Lobo, José Luis; Fernández-Reyes, José Luis; Ciammaichella, Maurizio; Monreal, Manuel; the RIETE Investigators:

    Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings

  • 047
    Candeloro, Matteo; Schulman, Sam:

    Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis

    Supplementary Material (PDF)
  • 055
    Iba, Toshiaki; Wada, Hideo; Levy, Jerrold H.:

    Platelet Activation and Thrombosis in COVID-19

  • 062
    Rizk, John G.; Gupta, Aashish; Lazo, Jose G.; Sardar, Partha; Henry, Brandon Michael; Lavie, Carl J.; Effron, Mark B.:

    To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years

    • Commentary

  • 073
    Lippi, Giuseppe; Henry, Brandon M.; Favaloro, Emmanuel J.:

    The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties

  • 076
    Cuker, Adam:

    The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness

  • 079
    Rizk, John G.; Lavie, Carl J.; Henry, Brandon Michael:

    Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients

  • 081
    Lippi, Giuseppe; Favaloro, Emmanuel J.:

    Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?

  • 085
    Rizk, John G.; Lazo, Jose G.; Gupta, Aashish; Lavie, Carl J.; Effron, Mark B.:

    Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients

    • Letter to the Editor

  • 089
    Tso, Allison C. Y.; Ong, Kiat H.; Sum, Christina L. L.; Fan, Bingwen E.; Chan, Grace Y. L.; Christopher, Dheepa; Howe, Hwee S.; Lai, Yi W.; Lim, Xin R.; Leung, Bernard P. L.:

    Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?

  • 092
    Zaid, Younes; Lahlimi, Qamar; Khalki, Loubna; Zaid, Nabil; Oudghiri, Mounia; Cheikh, Amine; Naya, Abdallah; Merhi, Yahye; Guessous, Fadila:

    Aspirin use Reduces Platelet Hyperreactivity and Degranulation in COVID-19 Patients

  • 097
    Arcani, Robin; Cauchois, Raphaël; Suchon, Pierre; Weber, Samuel; Jean, Rodolphe; Jarrot, Pierre-André; Rey, Louise; Venton, Geoffroy; Koubi, Marie; Muller, Romain; Bertin, Daniel; Mège, Jean-Louis; Kaplanski, Gilles; Bardin, Nathalie:

    “True” Antiphospholipid Syndrome in COVID-19: Contribution of the Follow-up of Antiphospholipid Autoantibodies

  • 103
    Carnevale, Sergio; Giovanetti, Marta; Benvenuto, Domenico; Ciccozzi, Massimo; Broccolo, Francesco:

    Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?

  • 105
    Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj:

    Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment

  • 106
    Benvenuto, Domenico; Carnevale, Sergio; Giovanetti, Marta; Ciccozzi, Massimo; Broccolo, Francesco:

    Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment